Literature DB >> 20410491

The TNF-like protein 1A-death receptor 3 pathway promotes macrophage foam cell formation in vitro.

James E McLaren1, Claudia J Calder, Brian P McSharry, Keith Sexton, Rebecca C Salter, Nishi N Singh, Gavin W G Wilkinson, Eddie C Y Wang, Dipak P Ramji.   

Abstract

TNF-like protein 1A (TL1A), a TNF superfamily cytokine that binds to death receptor 3 (DR3), is highly expressed in macrophage foam cell-rich regions of atherosclerotic plaques, although its role in foam cell formation has yet to be elucidated. We investigated whether TL1A can directly stimulate macrophage foam cell formation in both THP-1 and primary human monocyte-derived macrophages with the underlying mechanisms involved. We demonstrated that TL1A promotes foam cell formation in human macrophages in vitro by increasing both acetylated and oxidized low-density lipoprotein uptake, by enhancing intracellular total and esterified cholesterol levels and reducing cholesterol efflux. This imbalance in cholesterol homeostasis is orchestrated by TL1A-mediated changes in the mRNA and protein expression of several genes implicated in the uptake and efflux of cholesterol, such as scavenger receptor A and ATP-binding cassette transporter A1. Furthermore, through the use of virally delivered DR3 short-hairpin RNA and bone marrow-derived macrophages from DR3 knockout mice, we demonstrate that DR3 can regulate foam cell formation and contributes significantly to the action of TL1A in this process in vitro. We show, for the first time, a novel proatherogenic role for both TL1A and DR3 that implicates this pathway as a target for the therapeutic intervention of atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20410491      PMCID: PMC2874519          DOI: 10.4049/jimmunol.0903782

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  37 in total

1.  Re-engineering adenovirus vector systems to enable high-throughput analyses of gene function.

Authors:  Richard J Stanton; Brian P McSharry; Melanie Armstrong; Peter Tomasec; Gavin W G Wilkinson
Journal:  Biotechniques       Date:  2008-12       Impact factor: 1.993

2.  DR3 regulates negative selection during thymocyte development.

Authors:  E C Wang; A Thern; A Denzel; J Kitson; S N Farrow; M J Owen
Journal:  Mol Cell Biol       Date:  2001-05       Impact factor: 4.272

3.  Interferon-gamma impedes reverse cholesterol transport and promotes foam cell transformation in THP-1 human monocytes/macrophages.

Authors:  Allison B Reiss; Chirag A Patel; Mohammad M Rahman; Edwin S L Chan; Kowser Hasneen; Maria C Montesinos; Julie D Trachman; Bruce N Cronstein
Journal:  Med Sci Monit       Date:  2004-10-26

4.  Identification of a gamma-interferon-responsive element in the promoter of the human macrophage scavenger receptor A gene.

Authors:  T Grewal; E Priceputu; J Davignon; L Bernier
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-05       Impact factor: 8.311

Review 5.  Genetics of atherosclerosis.

Authors:  Aldons J Lusis; Rebecca Mar; Paivi Pajukanta
Journal:  Annu Rev Genomics Hum Genet       Date:  2004       Impact factor: 8.929

6.  Expression, localization, and functional activity of TL1A, a novel Th1-polarizing cytokine in inflammatory bowel disease.

Authors:  Giorgos Bamias; Charles Martin; Marco Marini; Sharon Hoang; Margarita Mishina; William G Ross; Muhammadreza A Sachedina; Charles M Friel; James Mize; Stephen J Bickston; Theresa T Pizarro; Ping Wei; Fabio Cominelli
Journal:  J Immunol       Date:  2003-11-01       Impact factor: 5.422

7.  Overexpression of human decoy receptor 3 in mice results in a systemic lupus erythematosus-like syndrome.

Authors:  Bing Han; Paul A Moore; Jiangping Wu; Hongyu Luo
Journal:  Arthritis Rheum       Date:  2007-11

Review 8.  The role of TNF superfamily members in T-cell function and diseases.

Authors:  Michael Croft
Journal:  Nat Rev Immunol       Date:  2009-04       Impact factor: 53.106

9.  Regulation of smooth muscle cell scavenger receptor expression in vivo by atherogenic diets and in vitro by cytokines.

Authors:  H Li; M W Freeman; P Libby
Journal:  J Clin Invest       Date:  1995-01       Impact factor: 14.808

10.  A critical role for the Sp1-binding sites in the transforming growth factor-beta-mediated inhibition of lipoprotein lipase gene expression in macrophages.

Authors:  Scott A Irvine; Pelagia Foka; Sarah A Rogers; James R Mead; Dipak P Ramji
Journal:  Nucleic Acids Res       Date:  2005-03-08       Impact factor: 16.971

View more
  42 in total

1.  The death receptor 3/TL1A pathway is essential for efficient development of antiviral CD4⁺ and CD8⁺ T-cell immunity.

Authors:  Jason P Twohig; Morgan Marsden; Simone M Cuff; John R Ferdinand; Awen M Gallimore; William V Perks; Aymen Al-Shamkhani; Ian R Humphreys; Eddie C Y Wang
Journal:  FASEB J       Date:  2012-05-16       Impact factor: 5.191

2.  On death receptor 3 and its ligands….

Authors:  Eddie C Y Wang
Journal:  Immunology       Date:  2012-09       Impact factor: 7.397

Review 3.  TL1A and DR3, a TNF family ligand-receptor pair that promotes lymphocyte costimulation, mucosal hyperplasia, and autoimmune inflammation.

Authors:  Françoise Meylan; Arianne C Richard; Richard M Siegel
Journal:  Immunol Rev       Date:  2011-11       Impact factor: 12.988

Review 4.  The TNF-family cytokine TL1A: from lymphocyte costimulator to disease co-conspirator.

Authors:  Arianne C Richard; John R Ferdinand; Françoise Meylan; Erika T Hayes; Odile Gabay; Richard M Siegel
Journal:  J Leukoc Biol       Date:  2015-07-17       Impact factor: 4.962

5.  Elevated levels of TL1A are associated with disease activity in patients with systemic sclerosis.

Authors:  Wangdong Xu; Linchong Su; Pingying Qing; Ying Wang; Yan Liang; Yi Zhao; Qiongxiu Zhou; Feng Ma; Yi Liu
Journal:  Clin Rheumatol       Date:  2017-04-10       Impact factor: 2.980

6.  Death Receptor 3 Promotes Chemokine-Directed Leukocyte Recruitment in Acute Resolving Inflammation and Is Essential for Pathological Development of Mesothelial Fibrosis in Chronic Disease.

Authors:  William V Perks; Ravinder K Singh; Gareth W Jones; Jason P Twohig; Anwen S Williams; Ian R Humphreys; Philip R Taylor; Simon A Jones; Eddie C Y Wang
Journal:  Am J Pathol       Date:  2016-09-21       Impact factor: 4.307

7.  TL1A inhibits atherosclerosis in apoE-deficient mice by regulating the phenotype of vascular smooth muscle cells.

Authors:  Dan Zhao; Jiaqi Li; Chao Xue; Ke Feng; Lipei Liu; Peng Zeng; Xiaolin Wang; Yuanli Chen; Luyuan Li; Zhisong Zhang; Yajun Duan; Jihong Han; Xiaoxiao Yang
Journal:  J Biol Chem       Date:  2020-09-22       Impact factor: 5.157

8.  SUSTAINED TL1A (TNFSF15) EXPRESSION ON BOTH LYMPHOID AND MYELOID CELLS LEADS TO MILD SPONTANEOUS INTESTINAL INFLAMMATION AND FIBROSIS.

Authors:  Libo Zheng; Xiaolan Zhang; Jeremy Chen; Ryan Ichikawa; Kori Wallace; Charalabos Pothoulakis; Hon Wai Koon; Stephan R Targan; David Q Shih
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2013-03

Review 9.  Cytokines: roles in atherosclerosis disease progression and potential therapeutic targets.

Authors:  Joe We Moss; Dipak P Ramji
Journal:  Future Med Chem       Date:  2016-06-30       Impact factor: 3.808

10.  The relationship between TNF-like protein 1A and coronary artery aneurysms in children with Kawasaki disease.

Authors:  Jing Zhang; Haobo Weng; Qiongfei Pei; Penghui Yang; Wentao Fan; Ruixi Liu; Qijian Yi
Journal:  Clin Exp Med       Date:  2021-07-07       Impact factor: 3.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.